Microbiologic and clinical implications of bacteremia due to extended-spectrum-β-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC β-lactamase DHA-1

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 12, 2010, Pages 5395-5398

  Lee, Chen Hsiang ^a,b   Su, Lin Hui ^a,b   Li, Chia Chin ^b   Chien, Chun Chih ^b   Tang, Ya Fen ^b   Liu, Jien Wei ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; BETA LACTAMASE AMPC; BETA LACTAMASE AMPC DHA 1; CARBAPENEM; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INFECTION RISK; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PLASMID; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CASE-CONTROL STUDIES; CIPROFLOXACIN; FEMALE; HUMANS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PENICILLANIC ACID; PIPERACILLIN; PLASMIDS; YOUNG ADULT;

EID: 78649661345     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00083-10     Document Type: Article

References (20)

1. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. M100-S20-U. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Goering, R. V. 2004. Pulsed-field gel electrophoresis, p. 185-196. In D. H. Persing, F. C. Tenover, J. Versalovic, Y. W. Tang, E. R. Unger, D. A. Relman and T. H. White (ed.), Molecular microbiology: diagnostic principles and practice. ASM Press, Washington, DC.
4. Grimm, H. 1991. Interpretive criteria of antimicrobial disk susceptibility tests with flomoxef. Infection 19(Suppl. 5):258-263.
5. Jacoby, G. A. 2009. AmpC β-lactamase. Clin. Microbiol. Rev. 22:161-182.
6. Lan, C. K., P. R. Hsueh, W. W. Wong, C. P. Fung, Y. T. Lau, J. Y. Yeung, G. T. Young, and C. C. Su. 2003. Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase- producing organisms. J. Microbiol. Immunol. Infect. 36:182-186.
7. Lee, C. H., L. H. Su, J. H. Chia, K. T. Tsai, T. L. Wu, and J. W. Liu. 2004. Recurrent Klebsiella pneumoniae mycotic aneurysm in a diabetic patient and emergence of an extended-spectrum beta-lactamase (CTX-M-24)-containing Klebsiella pneumoniae strain after prolonged treatment with first-generation cephalosporins for mycotic aneurysm. Microb. Drug Resist. 10:359-363.
8. Lee, C. H., L. H. Su, Y. F. Tang, and J. W. Liu. 2006. Treatment of ESBL-producing Klebsiella pneumoniae bacteremia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates. J. Antimicrob. Chemother. 58:1074-1077.
9. Lee, C. H., C. Chu, J. W. Liu, Y. S. Chen, C. J. Chiu, and L. H. Su. 2007. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 β-lactamases. J. Antimicrob. Chemother. 60:410-413.
10. Lee, J., H. Pai, Y. K. Kim, N. H. Kim, B. W. Eun, H. J. Kang, K. H. Park, E. H. Choi, H. Y. Shin, E. C. Kim, H. J. Lee, and H. S. Ahn. 2007. Control of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. J. Antimicrob. Chemother. 60:629-637.
11. Paterson, D. L., and R. A. Bonomo. 2005. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
12. Paterson, D. L., W. C. Ko, A. V. Gottberg, S. Mohapatra, J. M. Casellas, H. Goossens, L. Mulazimoglu G. Trenholme, K. P. Klugman, R. A. Bonomo, L. B. Rice, M. M. Wagener. J. G. McCormack, and V. L. Yu. 2004. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin. Infect. Dis. 39:31-37.
13. Pérez-Pérez, F. J., and N. D. Hanson. 2002. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiple PCR. J. Clin. Microbiol. 40:2153-2162.
14. Peterson, L. R. 2008. Antibiotic policy and prescribing strategies for therapy of extended-spectrum β-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. Clin. Microbiol. Infect. 14:S181-S184.
15. Petrikkos, G., A. Markogiannakis, J. Papaparaskevas, G. L. Daikos, G. Stefanakos, N. P. Zissis, and A. Avlamis. 2007. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital. Int. J. Antimicrob. Agents 29:34-38.
16. Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
17. Rodríguez-Baño, J., M. D. Navarro, L. Romero, M. A. Muniain, M. Cueto, J. Gálvez, E. J. Perea, and A. Pascual. 2008. Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Clin. Microbiol. Infect. 14:180-183.
18. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
19. Tumbarello, M., T. Spanu, M. Sanguinetti, R. Citton, E. Montuori, F. Leone, G. Fadda, and R. Cauda. 2006. Bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob. Agents Chemother. 50:498-504.
20. Wiener, J., J. P. Quinn, P. A. Bradford, R. V. Goering, C. Nathan, K. Bush, and R. A. Weinstein. 1999. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517-523.